Article3 Biotech2025

c-MET tyrosine kinase inhibitors reverse drug resistance mediated by the ATP-binding cassette transporter B1 (ABCB1) in cancer cells.

Somayeh Nazari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.